Magnalup S 1000mg/500mg Injection
Marketer
Lupin Ltd
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Magnalup S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be strictly under a physician's guidance. Complete the prescribed regimen; premature cessation may reduce efficacy. Missed doses should be avoided. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention. Allergic responses (rash, pruritus, edema, dyspnea) require prompt medical help. Disclose all current medications to your doctor prior to commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration are crucial for optimal recovery. Follow-up laboratory and diagnostic assessments may be requested to monitor treatment effectiveness.
Primary Ingredients of Magnalup S 1000mg/500mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Magnalup S 1000mg/500mg Injection
Managing bacterial illnesses
Major Benefits of Magnalup S 1000mg/500mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Magnalup S 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Magnalup S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Magnalup S 1000mg/500mg Injection works:
Magnalup S 1000mg/500mg Injection combines Cefoperazone, a bacterial cell wall synthesis inhibitor antibiotic, with Sulbactam, a beta-lactamase inhibitor. This pairing counters bacterial resistance, allowing Cefoperazone to effectively disrupt bacterial cell wall formation, thereby hindering bacterial survival.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Magnalup S 1000mg/500mg Injection treatment may induce adverse effects including facial flushing, tachycardia, nausea, thirst, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
Administering Magnalup S 1000mg/500mg Injection during pregnancy is usually deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Magnalup S 1000mg/500mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Magnalup S 1000mg/500mg Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Magnalup S 1000mg/500mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Magnalup S 1000mg/500mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Magnalup S 1000mg/500mg Injection :
Omitting a scheduled dose of Magnalup S 1000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Magnalup S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |







